Published on: 2025-09-20 09:00:18
There’s new hope for people struggling with an addiction to cocaine. In clinical trial results released today, an experimental drug developed by Novartis was found to reduce cocaine use in people with cocaine use disorder. Scientists at Novartis led the research, a Phase II trial of 68 people with diagnosed cocaine use disorder. Compared to those on a placebo, people taking the experimental treatment—called mavoglurant—used cocaine and also drank alcohol less often over the following three mont
Keywords: cocaine disorder mavoglurant people use
Find related items on AmazonGo K’awiil is a project by nerdhub.co that curates technology news from a variety of trusted sources. We built this site because, although news aggregation is incredibly useful, many platforms are cluttered with intrusive ads and heavy JavaScript that can make mobile browsing a hassle. By hand-selecting our favorite tech news outlets, we’ve created a cleaner, more mobile-friendly experience.
Your privacy is important to us. Go K’awiil does not use analytics tools such as Facebook Pixel or Google Analytics. The only tracking occurs through affiliate links to amazon.com, which are tagged with our Amazon affiliate code, helping us earn a small commission.
We are not currently offering ad space. However, if you’re interested in advertising with us, please get in touch at [email protected] and we’ll be happy to review your submission.